Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)

Hong Kong · Delayed Price · Currency is HKD

1.000

+0.010 (1.01%)

Aug 27, 2026, 3:47 PM HKT

-20.00% (1Y)

Market Cap	1.49B -20.7%
Revenue (ttm)	1.37B +16.1%
Net Income	238.11M -62.1%
EPS	0.16 -62.7%
Shares Out	1.51B
PE Ratio	6.35
Forward PE	n/a
Dividend	0.06 (6.33%)
Ex-Dividend Date	May 27, 2026

Volume	148,000
Open	0.980
Previous Close	0.990
Day's Range	0.980 - 1.005
52-Week Range	0.980 - 1.270
Beta	0.23
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About HKG:2348

Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, cephalosporin tablets, and other oral solid-dosage-form antibiotics. It also provides system specific medicines for various therapeutic areas, such as cardiovascular syst... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1995

Employees 1,081

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 2348

Full Company Profile

Financial Performance

In 2025, HKG:2348's revenue was 1.23 billion, an increase of 16.09% compared to the previous year's 1.06 billion. Earnings were 213.97 million, a decrease of -62.13%.

Financial numbers in CNY Financial Statements